Document:

Exhibit
10.2

 

Hemispherx
Biopharma, Inc.

Restricted
Stock Award

 

Grant
Notice

 

2018
Equity Incentive Plan

 

Hemispherx
Biopharma, Inc. (the “Company”), pursuant to its 2018 Equity Incentive Plan (the “Plan”), hereby grants
to Participant the right to receive the number of shares of the Company’s Common Stock set forth below (“Award”).
This Award is subject to all of the terms and conditions as set forth herein and in the Restricted Stock Award Agreement and the
Plan, each of which are attached hereto and incorporated herein in their entirety. Defined terms not explicitly defined in this
Grant Notice but defined in the Plan shall have the same definitions as in the Plan.

 

Participant:
_____________

Date
of Grant: _____________

Vesting
Date: ____________

Number of Shares Issuable Under the
Award: _____________

 

Vesting Schedule:
Subject to Participant’s
Continuous Service, the shares issuable pursuant to the Award shall vest and be issued on the six month anniversary
of the Date of Grant (the “Vesting Date”).

 

Additional
Terms/Acknowledgements: The undersigned Participant acknowledges receipt of, and understands and agrees to, this Grant Notice,
the Restricted Stock Award Agreement and the Plan. Participant further acknowledges that this Grant Notice, the Restricted Stock
Award Agreement and the Plan set forth the entire understanding between Participant and the Company regarding this award of Common
Stock in the Company.

 

	Hemispherx
    Biopharma, Inc.	 	Participant:
	 	 	 	 
	By:	    	 	By:	
	 	[NAME,
    TITLE]	 	 	[NAME]
	 	 	 	 	 
	 	 	 	Date:
    	 

 

	Attachments:	 
	 	 
	Attachment
    I:	Restricted
    Stock Award Agreement
	 	 
	Attachment
    II:	2018
    Equity Incentive Plan

 

    	 

    	 

    

 

Attachment
I

 

RESTRICTED
STOCK AWARD AGREEMENT

Hemispherx
Biopharma, Inc.

2018
Equity Incentive Plan

 

Restricted
Stock Award Agreement

 

Pursuant to
the Restricted Stock Award Grant Notice (“Grant Notice”) and this Restricted Stock Award Agreement (collectively,
the “Award”) and in consideration of your past and future services, Hemispherx Biopharma, Inc. (the
“Company”) has awarded you a restricted stock award under its 2018 Equity Incentive Plan (the “Plan”)
for the number of shares of the Company’s Common Stock issuable pursuant to the Award indicated in the Grant Notice.  Except
where indicated otherwise, defined terms not explicitly defined in this Restricted Stock Award Agreement but defined in the Plan
shall have the same definitions as in the Plan.

 

The
details of your Award are as follows:

 

1.Vesting.
Subject to the limitations contained herein, your Award shall vest as provided in your Grant Notice. “Vested
Shares” shall mean shares issuable to you under the Award on the Vesting Date set forth in the Grant Notice.
Notwithstanding the foregoing, your Award shall become vested in its entirety in the circumstances providing for accelerated
vesting under the terms of your written Employment Agreement with Hemispherx Biopharma, Inc., if any, as it may be amended from
time to time (the “Employment Agreement”) or such other applicable agreement, in each case, while your
Employment Agreement is in effect. When your Award vests, the Company shall issue the Vested Shares to you, either
in the form of one or more stock certificates or as uncertificated shares in electronic form, or in any combination of the foregoing.

 

2.
Number of Shares. The Number of shares issuable pursuant to this grant
shall be computed as follows: 25% of one-twenty-fourth (1/24) of the Participant’s annual salary divided by the per share
closing price of the Company’s Common stock on the NYSE American on the trading day prior to the Grant Date. The
number of shares issuable pursuant to your Award may be adjusted from time to time for Capitalization Adjustments, as provided
in Section 9(a) of the Plan.

 

3. Payment. This
Award was granted in consideration of your past and future services to the Company and its Affiliates or in consideration of
other legal consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable
law.

 

4. Securities
Law Compliance. You will not be issued any shares of Common Stock under your Award unless either (a) such shares
are then registered under the Securities Act or (b) the Company has determined that such issuance would be exempt from the
registration requirements of the Securities Act. Your Award must also comply with other applicable laws and regulations
governing the Award, and you will not receive such shares if the Company determines that such receipt would not be in
material compliance with such laws and regulations.

 

5.
Transfer Restrictions. Prior to the time that they have vested, you may not
transfer, pledge, sell or otherwise dispose of the Award. Notwithstanding the foregoing, you may, by delivering written notice
to the Company, in a form satisfactory to the Company, designate a third party who, in the event of your death, shall thereafter
be entitled to receive the Award as of the date of your death.

 

6.
Termination of Continuous Service. Except
as may be provided in your Employment Agreement, if any, and subject to Section 1 hereof, in the event your Continuous Service
terminates, all of your Award shall immediately be cancelled and of no further value.

 

7.
Restrictive Legends. The Vested Shares issued under your Award shall
be endorsed with appropriate legends determined by the Company as applicable.

 

8. Rights
as a Stockholder. Until the Award vests, you
shall not have any rights or privileges of a stockholder of the Company with respect to the shares issuable pursuant
to your Award.

 

    	 

    	 

    

 

9. Award
not a Service Contract. Nothing in this Agreement (including, but not limited to, the vesting of your Award or the
issuance of the shares issuable pursuant to your Award), the Plan or any covenant of good faith and fair dealing
that may be found implicit in this Agreement or the Plan shall: (i) confer upon you any right to continue in the employ of, or
in affiliation with, the Company or an Affiliate; (ii) constitute any promise or commitment by the Company or an Affiliate regarding
the fact or nature of future positions, future work assignments, future compensation or any other term or condition of employment
or affiliation; (iii) confer any right or benefit under this Agreement or the Plan unless such right or benefit has specifically
accrued under the terms of this Agreement or Plan; or (iv) deprive the Company of the right to terminate you at will and without
regard to any future vesting opportunity that you may have.

 

10. Tax
Consequences. You agree to review with your own tax advisors the federal, state, local and foreign tax consequences
of this investment and the transactions contemplated by this Agreement. You shall rely solely on such advisors and not on any
statements or representations of the Company or any of its agents. You understand that you (and not the Company) shall be responsible
for your own tax liability that may arise as a result of this investment or the transactions contemplated by this Agreement.

 

11. Notices.
Any notice or request required or permitted hereunder shall be given in writing to each of the other parties hereto and shall
be deemed effectively given on the earlier of (i) the date of personal delivery, including delivery by express courier, or delivery
via electronic means, or (ii) the date that is five (5) days after deposit in the United States Post Office (whether or not actually
received by the addressee), by registered or certified mail with postage and fees prepaid, addressed at the following addresses,
or at such other address(es) as a party may designate by ten (10) days’ advance written notice to each of the other parties
hereto:

 

Company:

 

Hemispherx
Biopharma, Inc.

Attn:
Corporate Secretary

2117
SW Highway 484

Ocala
FL 34473

 

Participant:
Your address as on file with the Company at the time notice is given

 

12.Miscellaneous.

 

(a)
The rights and obligations of the Company under your Award shall be transferable by the Company to any one or more persons
or entities, and all covenants and agreements hereunder shall inure to the benefit of, and be enforceable by, the Company’s
successors and assigns.

 

(b) You
agree upon request to execute any further documents or instruments necessary or desirable in the sole determination of the Company
to carry out the purposes or intent of your Award.

 

(c) You
acknowledge and agree that you have reviewed your Award in its entirety, have had an opportunity to obtain the advice of counsel
prior to executing and accepting your Award and fully understand all provisions of your Award.

 

(d) This
Agreement shall be subject to all applicable laws, rules, and regulations and to such approvals by any governmental agencies or
national securities exchanges as may be required.

 

(e) All
obligations of the Company under the Plan and the Agreement shall be binding on any successor to the Company, whether the existence
of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially
all of the business and/or assets of the Company.

 

13. Governing
Plan Document. Your Award is subject to all the provisions of the Plan, the provisions of which are hereby made a part
of your Award, and is further subject to all interpretations, amendments, rules and regulations which may from time to time be
promulgated and adopted pursuant to the Plan. In the event of any conflict between the provisions of your Award and those of the
Plan, the provisions of the Plan shall control.

 

14. Choice
of Law. The interpretation, performance and enforcement of this Agreement shall be governed by the law of the state
of Delaware without regard to such state’s conflicts of law rules.

 

15. Severability.
If all or any part of this Agreement or the Plan is declared by any court or governmental authority to be unlawful or invalid,
such unlawfulness or invalidity shall not invalidate any portion of this Agreement or the Plan not declared to be unlawful or
invalid.

 

Any
Section of this Agreement (or part of such a Section) so declared to be unlawful or invalid shall, if possible, be construed in
a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible while remaining
lawful and valid.

 

18. Amendment.
This Agreement may not be modified, amended or terminated except by an instrument in writing, signed by you and by a duly authorized
representative of the Company. Notwithstanding the foregoing, this Agreement may be amended solely by the Board by a writing which
specifically states that it is amending this Agreement, so long as a copy of such amendment is delivered to you, and provided
that, except as otherwise expressly provided in the Plan, no such amendment materially adversely affecting your rights hereunder
may be made without your written consent. Without limiting the foregoing, the Board reserves the right to change, by written notice
to you, the provisions of this Agreement in any way it may deem necessary or advisable to carry out the purpose of the Award as
a result of any change in applicable laws or regulations or any future law, regulation, ruling, or judicial decision, provided
that any such change shall be applicable only to rights relating to that portion of the Award which is then subject to restrictions
as provided herein.

 

    	2

    	 

    

 

Attachment
II

 

2018
EQUITY INCENTIVE PLAN

 

    	3EX-10.1

 Exhibit 10.1 

August 25, 2019 
 Eric J. Foss 

[ADDRESS WITHHELD FOR PRIVACY] 
 Dear Eric: 

This Letter Agreement and General Release (this “Letter Agreement”) will confirm our agreement regarding your role as Executive
Advisor and your subsequent retirement. For purposes of this Letter Agreement, “Aramark” shall include Aramark, Aramark Services, Inc., and each of their affiliates, subsidiaries, divisions, lines of business and any corporation, joint
venture, or other entity in which Aramark or its subsidiaries has an equity interest in excess of ten percent (10%). 
 We have agreed as
follows: 
 1.    Advisory Period and Retirement: 

(a)    Effective as of August 25, 2019 (the “Transition Date”), you hereby resign as Chairman, President and
Chief Executive Officer of Aramark, and from all other officer and director positions you may hold within Aramark, including as a member of the Board of Directors of Aramark Corporation (the “Board”). Beginning on the Transition Date and
ending on October 2, 2019 (the “Retirement Date” and such period, the “Advisory Period”), Aramark hereby appoints you to serve in the role of Executive Advisor. In such role, you will remain a full-time employee of Aramark
for purposes of Aramark’s employment policies, plans and practices and will continue to receive payments of your full annual base salary in accordance with Aramark’s regular payroll. During the Advisory Period, you will assist with the
transition of your duties, and provide such advisory services, in each such case as and where reasonably requested by the Board. At all times on and after the Transition Date, you shall not act for, bind or represent Aramark for any purpose, except
as may be reasonably requested by the Board. During the Advisory Period, you will provide services to Aramark on an exclusive basis and shall not provide services to any other entity. 

(b)    Your separation from service as an employee of Aramark will be effective upon the Retirement Date, unless you are
terminated earlier for Cause or you resign with or without Good Reason (each, as defined in the Agreement Relating to Employment and Post-Employment Competition between you and Aramark dated May 7, 2012, as amended June 25, 2013 (the
“Post Employment Competition Agreement”)). In the event your employment is terminated by Aramark for Cause or by you with or without Good Reason prior to the Retirement Date, the terms and conditions of your separation from service will be
governed by the Post Employment Competition Agreement, and this Agreement will be null and void ab initio. 

(c)    Effective upon the Retirement Date, you agree to resign as a member of the board of directors of any organization
for which you serve as a director by reason of your position as Chairman, President and Chief Executive Officer of Aramark, including but not limited to Catalyst. 

 2.     Separation Payments: In consideration for your
obligations under this Letter Agreement, including but not limited to the Release and Waiver of Claims attached as Appendix A to this Letter Agreement, and subject to the other provisions of this Letter Agreement, and in accordance with
(a) Section 1(a) of the Post Employment Competition Agreement, you shall receive payments of $141,666.66 per month, for a period of twenty-four (24) months, and (b) Section 1(b) of the Post Employment Competition Agreement,
you shall receive payments totaling two times your “Bonus” (i.e., the amount payable to you under the Management Incentive Plan (as defined in Paragraph 3 below) in respect of Aramark’s fiscal year ending September 27, 2019, it
being understood and agreed by the parties hereto that the percentage of such Bonus related to your achievement of your Individual Performance Objectives in respect of such fiscal year shall be determined to be achieved based on the same percentage
as Aramark’s actual achievement of the applicable Financial Objective metrics for fiscal year 2019 (the payments described in clauses (a) and (b) hereof, collectively, the “Separation Payments”). Separation Payments shall be paid
monthly, less all applicable withholding taxes and payroll deductions, and shall commence within sixty (60) days following the Retirement Date. The period during which you are eligible to receive your Separation Payments (the “Separation
Pay Period”) shall commence with the Retirement Date, assuming that you timely execute and do not revoke this Letter Agreement and the Release and Waiver of Claims attached as Appendix A to this Letter Agreement in accordance with each of the
terms hereof and thereof.  
 These payments shall constitute full satisfaction of any obligations owed to you by Aramark
under Sections 1(a) and 1(b) of the Post Employment Competition Agreement. 
 3.    Bonus Payments: 

(a)    In accordance with the terms of the Amended and Restated Executive Leadership Council Management Incentive Plan (the
“Management Incentive Plan”), an employee must be an employee of Aramark on the last day of the fiscal year in order to be eligible to receive a bonus for such fiscal year. Accordingly, you are eligible to receive your annual bonus under
the Management Incentive Plan for fiscal year 2019, which bonus will be based on actual achievement of the applicable Financial Objective metrics for fiscal year 2019 and, with respect to that portion of such bonus that is based on your achievement
of Individual Objective metrics, the same percentage as Aramark’s actual achievement of the applicable Financial Metrics for fiscal year 2019. You shall receive a payment of your fiscal year 2019 annual bonus, minus all applicable withholdings,
at the same time bonuses are typically paid under the Management Incentive Plan, but in no event later than March 15, 2020. 

(b)    By executing this Letter Agreement, you acknowledge and agree that you waive, and shall not be entitled to, any
payment that may otherwise be due under Section 1(c) of the Post Employment Competition Agreement with respect to any prorated bonus you may have been entitled to receive under the Management Incentive Plan in respect of Fiscal Year 2020. 

(c)    The bonus payment referenced in Paragraph 3(a) above shall constitute full satisfaction of any separation
obligation to you under Section 1(c) of the Post Employment Competition Agreement. You may receive separate correspondence from Aramark regarding your bonus, but, in the meantime, you can obtain further details from Lynn McKee. 

  
 2 

 4.    Group Insurance; Vacation; Leased Vehicle; Reimbursement of
Expenses: 
 (a)    If you execute this Letter Agreement and the Release and Waiver of Claims attached as
Appendix A to this Letter Agreement and do not revoke this Letter Agreement and Appendix A, then you will continue to be eligible to receive group medical and life insurance coverages during the Separation Pay Period under Aramark’s plans in
which you were participating immediately prior to your Retirement Date in accordance with your benefits elections, subject to the terms of the applicable plan documents and to such changes to the terms of such plans as Aramark determines to apply to
its employees (the period of time during which you receive the relevant coverages from Aramark shall be referred to hereinafter as the “Benefits Continuation Period”). 

During the Benefits Continuation Period, the cost of your group medical and life insurance coverages shall continue to be subsidized by Aramark and your share
of the premiums will be deducted from your Separation Payments. 
 Your rights under COBRA to continue your group medical insurance coverages beyond the
Benefits Continuation Period are at your expense. Please note that your rights under COBRA commence with the Retirement Date and run concurrently with the Benefits Continuation Period. You must elect COBRA coverage in accordance with the information
that will be sent to you.    Note that due to your separation from service, you have the option to elect coverage under the Public Health Exchange as an alternative to COBRA. If you elect coverage, you will not be eligible to
enroll for coverage on the Public Health Exchange until you have exhausted your COBRA coverage, until the next Public Health Exchange open enrollment period or if you qualify for a Public Health Exchange special enrollment opportunity. 

If you become employed by a new employer at any time during the Separation Pay Period, continued coverages under this Paragraph 4 shall become secondary to
any such coverages provided to you by the new employer. 
 In addition, you may have the ability to convert certain
non-health insurance coverages to individual policies. Further information regarding coverage continuation and conversion may be obtained from Lynn McKee. Notwithstanding the foregoing, Aramark reserves the
right to restructure the provision of continued medical coverage in any manner necessary or appropriate to avoid fines, penalties or negative tax consequences to Aramark or you (including, without limitation, to avoid any penalty imposed for
violation of the nondiscrimination requirements under the Patient Protection and Affordable Care Act or the guidance issued thereunder), as determined by Aramark in its sole and absolute discretion. 

(b)    You will continue to receive your monthly company car allowance of $2,000 per month through the Separation Pay
Period, provided that to receive such allowance, you must execute this Letter Agreement and the Release and Waiver of Claims attached as Appendix A to this Letter Agreement and must not revoke the Letter Agreement or Appendix A. This allowance is
subject to all applicable withholding taxes. 

  
 3 

 (e)    You will be reimbursed, in accordance with normal Aramark policy,
for any business expenses you incurred on or before October 2, 2019 and which are submitted to Aramark for reimbursement on or before October 25, 2019. 

(f)    You will receive payment for any earned, accrued and unused vacation through the Transition Date. You will not
accrue any vacation days following the Transition Date. 
 5.    No Other Amounts Due: You
acknowledge that Aramark has paid you all wages, salaries, bonuses, benefits, and other amounts earned and accrued, less applicable deductions, and that Aramark has no obligation to pay any additional amounts other than the payment(s) and benefits
described in this Letter Agreement. 
 6.    Other Executive Benefits and Perquisites: Your
membership in the Executive Leadership Council and Executive Leadership Team shall terminate as of the Transition Date. Notwithstanding the foregoing, all Executive Leadership Council benefits including, but not limited to, your Executive Health
Plan, Executive Physical Program and Executive Supplemental Long-Term Disability shall continue to be provided until the Retirement Date and shall terminate, unless otherwise provided under the applicable plan or program, as of the Retirement Date,
provided that your Executive Health Plan benefits shall terminate on the last day of the month in which your Retirement Date falls. Consistent with the provision of benefits as described in Paragraph 4 above, you do have certain rights under
COBRA to elect to continue your Executive Health Plan coverage at your expense. You shall receive additional information regarding your option to continue this coverage. Further information regarding coverage continuation and conversion may be
obtained from Lynn McKee. In addition, notwithstanding your ceasing to serve as an officer of Aramark, the services of your current executive assistant will be made available to you until the Retirement Date. 

7.    Aramark Retirement Plans: You have an account balance under the Aramark Savings
Incentive Retirement Plan (the “SIRP”), your active participation under the SIRP will terminate as of the Retirement Date. Under the terms of the SIRP, you will not be eligible to make further salary deferrals following the Retirement
Date. However, since you satisfy certain age and service requirements under the SIRP (age 60 or older with greater than 5 years of service with Aramark), you will be eligible to receive the company matching contribution for 2019 based on your
contributions to the SIRP prior to the Retirement Date. The company match is determined annually and will be deposited into your SIRP account at the same time as all other SIRP participants. Processing of your account(s) for distribution over the ten-year period you have previously elected will begin after the Retirement Date in accordance with the terms of the SIRP. You may obtain further details on SIRP distributions from Lynn McKee. 

 

	 	8.    Equity/Stock	 Plans: 

(a)    Equity-Based Awards: The effect the separation of your service with Aramark will have on
your rights, if any, with respect to any outstanding Aramark stock options or other equity-based awards that you may hold immediately prior to the Retirement Date (collectively, the “Equity Awards”) will be as set forth in the terms of the
Post Employment Competition Agreement and the applicable Aramark incentive plan and award documents or agreements, including those terms applicable to your Retirement (as such 

  
 4 

 
term is defined in such Equity Awards) on the Retirement Date, a list of your Equity Awards and the effect of your separation from service is set forth as Appendix B hereto. Your Equity Award
records will be updated by Fidelity, Aramark’s equity program administrator, as soon as administratively possible following the Retirement Date and its website will display the remaining vested Equity Awards with each award’s revised
expiration date (i.e., for stock options, one year from the Retirement Date). You may view your Equity Award records on Fidelity’s website at https://nb.fidelity.com/public/nb/default/home or contact a Customer Service Representative at
Fidelity at 1-800-544-9354. You may receive separate correspondence from Fidelity regarding these awards, but in the meantime,
you can obtain further details as to the effect your separation from service will have on such awards from Lynn McKee. 
 (b) Stock of
Aramark: The records for the Aramark common stock that you own, if applicable, will continue to be kept by Aramark’s current transfer agent, Fidelity or, if applicable, its former transfer agent, Computershare, or their
successors, until you sell the stock or transfer it to a broker. If your stock is pledged as collateral or otherwise restricted on the transfer agent’s records, your stock will remain restricted and unavailable for sale or transfer pending
resolution of the underlying restriction. You can view your holdings on Fidelity’s or Computershare’s websites. 

9.    Aircraft Time Sharing: Effective as of the Retirement Date, that certain Aircraft Time
Sharing Agreement between you and Aramark (the “Aircraft Time Sharing Agreement”) shall terminate, notwithstanding any requirement to provide advance notice thereof under such agreement, which you hereby waive; provided,
however, that your use of the Aramark aircraft between the date hereof and the Retirement Date shall be in accordance with such agreement (including Paragraph 5 thereof) and limited to a maximum of two (2) round-trip flights, unless
otherwise agreed by the Chairman of the Board. 
 10.    Withholding: You are solely
responsible for the payment of any and all taxes that result from the payments and benefits due to you under this Letter Agreement. Aramark may, to the extent permitted by law, withhold applicable federal, state and local income and other taxes from
any payments due to you hereunder. 
 11.    Return of Aramark Property: On or before the
Retirement Date, you shall return to Aramark all documents, manuals, computers, computer programs, discs, drives, customer lists, notebooks, reports and other written or graphic materials, including all copies thereof, relating in any way to
Aramark’s business and prepared by you or obtained by you from Aramark, its affiliates, clients or its suppliers during the course of your employment with Aramark. Further, to the extent that you made use of your own personal computing devices
(e.g., PDA, smart phone, laptop, thumb drive, etc.) during your employment with Aramark, subject to any applicable litigation hold directive that you received and that remains in effect, you agree to provide such devices to Aramark in order for
Aramark to either permanently delete all Aramark property and information from such personal computing devices or replace same (which replacement shall include any personal information as contained on such devices). 

12.    Post-Employment Restrictions; Entire Agreement: This Letter Agreement and its
Appendices A and B, and any restrictive, clawback or other applicable covenants that apply on and following any separation from service under any Equity Awards, as applicable, constitutes the entire agreement between the parties on the subject of
payments and 

  
 5 

 
benefits due to you upon your separation from service with Aramark and post-employment payments and benefits; and, except as expressly provided herein, supersedes all other prior agreements
concerning the terms of any and all payments and benefits to which you may be entitled upon your separation from service, including the Post Employment Competition Agreement, except that the provisions of Articles 1 (Non-Disclosure and Non-Disparagement), 2 (Non-Competition), 3 (Non-Solicitation), 4
(Discoveries and Works), 5 (Remedies), 6.E (Post-Employment Benefits), 8.A, B, G, H, and I (Miscellaneous) of the Post Employment Competition Agreement, shall continue to apply and are hereby made a part of this Letter Agreement by reference.
Notwithstanding any provision in this Letter Agreement to the contrary, all payments hereunder are expressly made contingent on your compliance in all respects with all of the terms and conditions of the above-referenced provisions of Articles 1, 2,
3 and 4 of the Post Employment Competition Agreement. To the extent that you breach any of the restrictive covenants set forth in Articles 1, 2, 3 or 4 from the Post Employment Competition Agreement incorporated by reference in this Paragraph 12,
Aramark will, in accordance with the terms of Paragraph 6.E of the Post Employment Competition Agreement, have the right to cease payment of any unpaid Separation Payments and post-employment benefits, and otherwise will continue to have the
clawback rights under the Equity Awards.     
 13.    Remedies: You
acknowledge and agree that Aramark may seek injunctive relief in any court of competent jurisdiction for your failure to comply fully with any of the covenants referenced in Paragraph 12 and any other remedies as may be specified in the Post
Employment Competition Agreement and Equity Awards, as applicable, in addition to any other legal and monetary remedies which may be available to Aramark. 

14.    Agreement and Obligation to Cooperate: In exchange for the benefits provided to you by
Aramark under this Letter Agreement, you agree to cooperate fully with Aramark in any investigation instituted by Aramark or any other person or entity into any Aramark business involving the time period during which you were employed by Aramark.
This duty to cooperate will include, but not be limited to, meeting with representatives of Aramark at times and places reasonably designated by Aramark, and shall continue beyond the Separation Pay Period. 

15.    Certification of Compliance with Business Conduct Policy and Laws: By signing this
Letter Agreement, you are certifying that you have not violated Aramark’s Business Conduct Policy. 

16.    Section 409A of the Internal Revenue Code: This Letter Agreement is intended to comply
with Section 409A of the Internal Revenue Code of 1986, as amended, and its corresponding regulations (“Section 409A”), or an exemption thereto, and shall in all respects be administered in accordance with Section 409A, if
applicable. For purposes of Section 409A, payments may only be made under this Letter Agreement upon an event and in a manner permitted by Section 409A, including the requirement that nonqualified deferred compensation subject to
Section 409A cannot be paid to a “specified employee” as that term is defined under Section 409A until a date that is six months following a “separation from service” within the meaning of such term under
Section 409A. For purposes of Section 409A, all payments to be made upon a retirement under this Letter Agreement may only be made upon a “separation from service,” each payment made under this Letter Agreement shall be treated
as a separate payment and the right to a series of installment payments under this Letter Agreement is to be treated as a right to a series of separate payments. In no event shall you, directly or indirectly, designate the calendar year of payment
of any 

  
 6 

 
severance benefits that are subject to Section 409A. Any amounts paid hereunder that are subject to Section 409A and that could be paid in more than one taxable year based on the date
that you sign this Letter Agreement and the Release and Waiver of Claims attached as Appendix A to this Letter Agreement will be paid in the second taxable year. All reimbursements and in-kind benefits
provided under this Letter Agreement shall be made or provided in accordance with the requirements of Section 409A. 

17.    No Offset: If you do become employed or engaged elsewhere, the payments and benefits
set forth in this Letter Agreement shall continue and shall not be offset or reduced by any compensation or benefits you may receive from such other source, subject only to the requirements of the Post Employment Competition Agreement provisions
incorporated herein and the group medical and life insurance benefits set forth in Paragraph 4 above. 

18.    Severability: In the event that any portion of this Letter Agreement (including
Appendix A) is held to be invalid, unlawful, or unenforceable for any reason, the invalid, unlawful, or unenforceable portion shall be construed or modified in a manner that gives force and effect to the release of claims set forth in Appendix A and
the remainder of this Agreement to the fullest extent possible. If the invalid, unlawful or unenforceable portion cannot be construed or modified to render it valid, lawful, and enforceable, that portion shall be construed as narrowly as possible
and shall be severed from the remainder of this Agreement, and the remainder of this Agreement shall remain in effect and be construed as broadly as possible, as if the invalid, unlawful, or unenforceable portion had never been contained in this
Agreement. 
 19.    Applicable Law: This Letter Agreement shall be governed by and
construed in accordance with the laws of the Commonwealth of Pennsylvania, without regard to conflicts of laws principles thereof. 

20.    Amendment: This Letter Agreement may only be amended or modified by a written agreement
executed by you and Aramark (or any successor). 
 21.    Counterparts: This Letter
Agreement may be executed in one or more counterparts, which shall, collectively or separately, constitute one agreement. 

22.    Advice of Counsel: Aramark is advising you to have legal counsel, at your expense,
review this Letter Agreement and in particular the Release and Waiver of Claims attached as Appendix A, before you sign this Letter Agreement. 

23.    Non-Disparagement: Aramark, each member of
Aramark’s Board, and each of the executive officers of Aramark shall refrain from making any statements or comments of a defamatory or disparaging nature to any third party about you, other than to comply with law. In accordance with the Post
Employment Competition Agreement, you shall refrain from making any statements or comments of a defamatory or disparaging nature to any third party regarding Aramark, or any of Aramark’s officers, directors, personnel, other service providers,
policies or products or services, other than to comply with law. 

  
 7 

 Please sign the enclosed copy of this Letter Agreement to signify your understanding and
acceptance of the terms and conditions contained herein and return one original to me by no later than 5:00PM (Eastern Daylight Time) on August 24, 2019. 

 

			
	Very truly yours,
		
	By:	 	 /s/ Stephen I. Sadove

		 	Stephen I. Sadove

 Enclosures 

  
 8 

 The foregoing has been read and accepted as a binding agreement between Aramark and the
undersigned this 25th day of August, 2019. 
  

	
	 /s/ Eric J. Foss

	Eric J. Foss

  
 9 

 APPENDIX A 

Release and Waiver of Claims 

1.    In consideration for the payments provided for under the Letter Agreement between me, Eric J. Foss, and Aramark
dated August 25, 2019 (the “Letter Agreement”) and the Agreement Relating to Employment and Post-Employment Competition between me, Eric J. Foss, and Aramark Corporation dated May 7, 2012, as amended June 25 2013 (“Post
Employment Competition Agreement”), and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, I hereby agree on behalf of myself, my spouse, agents, assignees, attorneys, successors, assigns,
heirs and executors, to fully and completely release Aramark (which term shall be deemed to include Aramark Corporation, Aramark Services, Inc., and all subsidiary and affiliated and successor companies or other entities in which Aramark or Aramark
Services, Inc., or their subsidiaries or affiliates has or had an equity interest in excess of ten percent (10%)), and their predecessors and successors and all of their respective past and/or present officers, directors, partners, members, managing
members, managers, employees, agents, representatives, administrators, attorneys, insurers, shareholders, bondholders, clients, customers, suppliers, distributors, subcontractors, joint-venture partners, consultants and fiduciaries in their
individual and/or representative capacities (hereinafter collectively referred to as the “Aramark Releasees”), to the fullest extent permitted by law, from any and all causes of action and claims whatsoever, which I or my heirs, executors,
administrators, successors and assigns ever had or now have against the Aramark Releasees or any of them, in law, admiralty or equity, whether known or unknown to me, for, upon, or by reason of, any matter, action, omission, course or thing in
connection with or in relationship to: (a) my employment or other service relationship with Aramark; (b) the termination of any such employment or service relationship; (c) any applicable employment, benefit, compensatory or equity
arrangement with Aramark occurring or existing up to the Retirement Date; and (d) any equity or stock plans of Aramark (such released claims are collectively referred to herein as the “Released Claims”). 

2.    The Released Claims include, without limitation of the language of paragraph 1, (i) any and all claims under Title
VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act of 1967, the Civil Rights Act of 1991, the Employee Retirement Income Security Act of 1974, the Americans with Disabilities Act, the Family and Medical Leave Act of 1993,
the Worker Adjustment Retraining and Notification Act, the Pennsylvania Human Relations Act (including any claims threatened or pending before the Pennsylvania Human Relations Commission), the Pennsylvania Whistleblower Law and any and all other
federal, state or local laws, statutes, rules and regulations pertaining to employment; and (ii) any claims for wrongful discharge, breach of express or implied contract, fraud, misrepresentation or any claims relating to benefits, compensation
or equity, or any other claims under any statute, rule or regulation or under the common law, including compensatory damages, punitive damages, attorney’s fees, costs, expenses and all claims for any other type of damage or relief. 

3.    The Released Claims shall not include: (i) any vested benefits which I hold under any Aramark pension or
welfare benefit plan; (ii) any claims to enforce my contractual rights under, or with respect to, the Letter Agreement; (iii) any rights to workers’ compensation benefits or unemployment insurance as required by applicable law, or
(iv) any claims that arise after the date on which I execute this Release and Waiver of Claims. The 

 
Release and Waiver of Claims does not apply to any claim that cannot be released in this Agreement as a matter of law. In addition, nothing herein prevents me from filing a charge or complaint
with the Equal Employment Opportunity Commission (“EEOC”) or similar state or local agency or my ability to participate in any investigation or proceeding conducted by the EEOC or such similar state or local agency; provided however, that
pursuant to Paragraphs 1 and 2 of this Release and Waiver of Claims, I am waiving, to the fullest extent permitted by law, any right to recover monetary damages or any other form of personal relief in connection with any such charge, investigation
or proceeding. To the extent I receive any personal or monetary relief in connection with any such charge, investigation or proceeding, Aramark will be entitled to an offset for the payments made pursuant to Paragraph 2 of the foregoing letter
agreement. 
 Nothing in the Letter Agreement or this Release and Waiver of Claims shall prohibit or restrict me or my attorneys from lawfully, and without
notice to Aramark: (a) initiating communications directly with, cooperating with, providing information to, causing information to be provided to, or otherwise assisting in an investigation by any governmental or regulatory agency, entity, or
official(s) (collectively, “Governmental Authorities”) regarding a possible violation of any law; (b) responding to any inquiry or legal process directed to me individually (and not directed to Aramark and/or its subsidiaries) from
any such Governmental Authorities; (b) testifying, participating or otherwise assisting in an action or proceeding by any such Governmental Authorities relating to a possible violation of law; or (d) making any other disclosures that are
protected under the whistleblower provisions of any applicable law. Additionally, pursuant to the federal Defend Trade Secrets Act of 2016, I shall not be held criminally or civilly liable under any federal or state trade secret law for the
disclosure of a trade secret that: (a) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a
suspected violation of law; or (b) is made to my attorney in relation to a lawsuit for retaliation against me for reporting a suspected violation of law; or (c) is made in a complaint or other document filed in a lawsuit or other
proceeding, if such filing is made under seal. Nor does this Letter Agreement or Appendix A require me to obtain prior authorization from Aramark before engaging in any conduct described in this Paragraph, or to notify Aramark that I have
engaged in any such conduct. 
 4.    I expressly understand and agree that the obligations of Aramark as set forth in
the Letter Agreement are in lieu of any and all other amounts which I might be, am now, or may become, entitled to receive from Aramark upon any claim released herein. I also expressly understand and agree that the separation payments paid to me
under the Letter Agreement is in addition to what I would otherwise be entitled to receive following the end of my employment. Other than as provided in the Letter Agreement, I acknowledge and agree that I have received all entitlements due from
Aramark relating to my employment with Aramark including, but not limited to, all wages earned, bonuses, sick pay, vacation pay and any other paid and unpaid leave for which I was eligible and to which I was entitled, and that no other entitlements
are due to me other than as set forth in the Letter Agreement. 

  
 2 

 5.    I acknowledge that the Older Workers Benefit Protection Act
(“OWBPA”) requires Aramark to provide me with the following disclosures to ensure my release and waiver of claims under the federal Age Discrimination in Employment Act is knowing and voluntary and I acknowledge and agree as follows: 

 

	 	a.	 I have read carefully and fully understand the terms of this Release and Waiver of Claims and that Aramark
advises me by the Letter Agreement to consult with an attorney and further I have had the opportunity to consult with an attorney prior to signing this Release and Waiver of Claims. 

 

	 	b.	 I fully understand the Release and Waiver of Claims that I am signing. 

 

	 	c.	 I am signing this Release and Waiver of Claims voluntarily and knowingly and I have not relied on any
representations, promises or agreements of any kind made to me in connection with my decision to accept the terms of this Release and Waiver of Claims, other than those set forth in this Release and Waiver of Claims and the Letter Agreement.

  

	 	d.	 I have been given at least twenty-one (21) days to consider
whether I want to sign this Release and Waiver of Claims. To the extent I have executed this Release and Waiver of Claims within less than twenty-one (21) days after its delivery to me, my decision to
execute this Release and Waiver of Claims prior to the expiration of such twenty-one (21) day period was entirely voluntary. 

 

	 	e.	 Any changes to the Letter Agreement or this Release and Waiver of Claims made by Aramark, whether material or
immaterial, do not restart the running of the twenty-one (21) day consideration period. 

  

	 	f.	 I have the right to revoke this Release and Waiver of Claims within seven (7) days after it is signed by
me. I further acknowledge that I will not receive any payments or benefits due to me under the Letter Agreement before the seven (7) day revocation period (the “Revocation Period”) has passed and then only if I have not revoked this
Release and Waiver of Claims. 

 This Release and Waiver of Claims shall take effect on the first business day following the expiration of
the Revocation Period, provided this Release and Waiver of Claims has not been revoked by me as provided above during such Revocation Period. 
 Intending
to be legally bound, I hereby execute this Release and Waiver of Claims. 
  

	
	  

	Eric J. Foss

 DATED: October     , 2019 

  
 3 

 APPENDIX B 

Equity Awards 
  

							
	 	 	 Grant Date
	 	 Grant Price
	 	 Units / Options

Outstanding

	Options	 	6/6/2012	 	$13.90	 	725,000
		 	6/6/2012	 	$13.90	 	725,000
		 	6/20/2013	 	$16.21	 	1,247,638
		 	7/31/2013	 	$16.21	 	342,998
		 	12/20/2013	 	$23.92	 	770,417
		 	11/19/2014	 	$28.66	 	627,262
		 	11/20/2015	 	$32.65	 	418,163
		 	11/18/2016	 	$34.08	 	141,844
		 	11/18/2016	 	$34.08	 	468,086
		 	11/16/2017	 	$40.74	 	339,429
		 	11/16/2017	 	$40.74	 	102,858
		 	11/15/2018	 	$36.74	 	430,623
				
	RSUs	 	11/20/2015	 	$0.00	 	15,812
		 	11/18/2016	 	$0.00	 	29,963
		 	11/16/2017	 	$0.00	 	37,187
		 	11/16/2017	 	$0.00	 	15,025
		 	11/15/2018	 	$0.00	 	65,960
				
	PSUs	 	11/18/2016	 	$0.00	 	116,198
		 	11/18/2016	 	$0.00	 	35,212
		 	11/18/2016	 	$0.00	 	18,159
		 	11/16/2017	 	$0.00	 	123,955
		 	11/16/2017	 	$0.00	 	37,562
		 	11/15/2018	 	$0.00	 	164,900

 Effect of Separation from Service on Equity Awards: 

In accordance with Paragraph 6(A)(2)(c) of the Post Employment Competition Agreement, all Time Options (as defined in such Paragraph 6(A)(2)(c)) scheduled to
vest in November 2019 and November 2020 will vest immediately upon the Retirement Date. Such Time Options and all other vested Aramark stock options will remain exercisable after your Retirement Date for the period set forth in the applicable stock
option award agreement. 
 In accordance with terms applicable to “Retirement” (as defined in the Equity Awards), upon the Retirement Date: 

 

	 	•	 	 All time-based restricted stock units scheduled to vest in November 2019 will remain outstanding and vest on the
original vesting date in November 2019. 

  

	 	•	 	 2016 PSUs will remain outstanding and fully vest (if at all) based on actual performance, on the normal vesting
schedule. 

  

	 	•	 	 2017 PSUs will remain outstanding and fully vest (if at all) based on actual performance, on the normal vesting
schedule. 

  

	 	•	 	 2018 PSUs will remain outstanding and vest (if at all) based on actual performance, as to two-thirds of the total award granted, on the normal vesting schedule.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}]]